1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NCI Transition Career Development Award (K22) is sponsored by National Cancer Institute (NCI). This award supports mentored, non-independent investigators in transitioning to their first independent tenure-track faculty cancer research positions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The NCI Transition Career Development Award (K22) As of November 13, 2025, NCI is no longer accepting K22 applications. For details, see NOT-CA-24-079 . Please note: K22 applications that were submitted to NCI prior to November 13, 2025, will still be reviewed and considered for funding in fiscal year 2026.
The NCI Transition Career Development Award (K22) supports mentored, non-independent investigators ready to transition to independent academic faculty positions. Note: The details on this page are for informational purposes only. Please read and follow all requirements and instructions in the notice of funding opportunity (NOFO) and the Table of IC-Specific Information linked therein before applying for an award.
Application review information is described in the funding opportunity. If you have any questions before submitting your application, please contact the relevant NCI program staff listed at the end of this page. For more complete information, reference the funding opportunity PAR-24-117 (K22 Independent Clinical Trial Optional) , and/or contact the program staff.
General Award Information Frequently Asked Questions Do you have questions about your NCI application or award for training in cancer research or education? Make the NCI Frequently Asked Questions your first stop to getting answers!
The objective of the NCI Transition Career Development Award (K22) is to provide support to mentored, non-independent investigators in transitioning to their first independent tenure-track faculty cancer research positions, or their equivalent. It is expected that the Research Plan be based on the candidate’s original project ideas and/or hypotheses.
The K22 project can be within the overall scope of the postdoctoral mentor’s research awards. However, there should be no text duplication or duplication of the scientific aims, and the candidate’s application should propose a scientific research question or approach that is distinct from the mentor’s pending or active research grants.
NCI will not support both a K22 award and an active or pending research grant that propose substantially the same research. Extension of Eligibility Window for Childbirth: NCI will approve a K22 eligibility extension of 1 year for childbirth for women applicants within the 8-year eligibility window beginning with the October 12, 2021 due date for application submission.
Applicants who will be the PD/PI on a K22 application must provide the child’s date of birth in the extension request justification to the NCI program director listed in the NOFOs at least 12 weeks before submitting an application.
Men, those who have adopted children, and same-sex partners of individuals giving birth are not eligible for the automatic one-year extension for childbirth, but, can request an extension for childbirth or adoption-related time away from research that will be approved on a case-by-case basis.
Citizenship At the time of the award, the candidate must be: a citizen of the United States or must have been lawfully admitted for permanent residence and possess an Alien Registration Receipt Card (1-151 or 1-551) or some other verification of legal admission as a permanent resident. Citizenship or green card is not needed to apply. Citizenship or green card is needed at the time of award issuance.
Foreign Nationals with Student Visas Not eligible for this award Career Stage Clinical or research fellows working in all areas of cancer research ready to transition to independent academic tenure-track assistant faculty positions. Applicants must have ≥ 2 years and ≤ 8 years of mentored, non-independent research training experience after the terminal doctorate at the time of application, including re-submission.
Individuals who currently hold, or previously held, a tenure-track faculty position, or its equivalent, are not eligible. Individuals who currently have, or previously had, an individual NIH career development award, or its equivalent, are not eligible. Effort Level/ Commitment Candidate must commit a minimum of 9 person months (75%) full-time professional effort to the K22 Career Development Award.
Duration of Award 3 years; the K22 Award is not renewable Salary Up to $100K/year + fringe benefits Research Development Support: Salaries for Technical Support, Consultant Costs, Equipment, Supplies, Travel, and Statistical Support Up to $50K/year F&A Costs/Indirect Costs 8% Ancillary Personnel Support: Salary for Mentors, Secretarial and Administrative Assistance, etc. Not allowed Applications must be submitted electronically.
Applicants must follow the instructions in the SF424(R&R) Application Guide, as well as any program-specific instructions noted in Section IV. of the Program Announcement. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions in Program Announcement.
Applications that do not comply with these instructions may be delayed or not be accepted for review. For assistance with application submission, please see the Frequently Asked Questions and/or contact eRA Commons Help Desk/Grant. gov contact Center .
Application Receipt Dates and Review Schedule Receipt Cycle Receipt Date: New Application Receipt Date: Resubmission Application Initial Review Council Review Earliest Possible Start Date* 1 February 12 March 12 June / July September / October December 2 June 12 July 12 October / November January / February April 3 October 12 November 12 February / March May / June July * Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Applications are due by 5 pm local time. When a standard submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day. Review and Selection Process The Center for Scientific Review (CSR) and the National Cancer Institute (NCI) review applications for completeness and for conformance to all eligibility requirements and special provisions and requirements.
Incomplete applications will be returned to the applicant without further consideration. Peer Review Panel to be determined by CSR. Before an award is made, the National Cancer Advisory Board (NCAB) conducts a second level of review and ensures that an application meets the broad program needs and priorities of the NCI and the National Cancer Program.
For review criteria for the K22 grant mechanism, see Section V. Application Review Information of the Program Announcement.
Funding Opportunity PAR-24-117 (K22 Independent Clinical Trial Optional) Current List of K22 Awards ZCA1 RTRB-R(02) Special Emphasis Panel Overview of the Grant Process NCI Resources for Researchers NIH Grants Policy Statement (GPS) - see section 12 Clarification of K Salary Supplementation For additional information regarding policies and/or guidance in preparing an application for the K22 Award, contact: For information regarding fiscal and/or budget issues, contact: Office of Grants Administration Email: NCIFinancialContact@nih.
gov For information regarding referral issues, contact: Email: ncirefof@dea. nci. nih.
gov For information regarding review issues, contact: Center for Scientific Review, Division of Receipt & Referral Email: csrdrr@mail. nih. gov Scientific Review Officer Email: found in your eRA Commons account
According to the current listing, eligibility includes: Individuals with at least 2 years, but no more than 8 years, of mentored, non-independent research training experience after their terminal research doctorate or clinical degree. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000/year for salary + fringe benefits; up to $50,000/year for research development support. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NCI Transition Career Development Award (K22) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article